Home Medicine Molecular and clinical findings of Turkish patients with hereditary fructose intolerance
Article
Licensed
Unlicensed Requires Authentication

Molecular and clinical findings of Turkish patients with hereditary fructose intolerance

  • Mehmet Gunduz , Özlem Ünal-Uzun , Nevra Koç , Serdar Ceylaner , Eda Özaydın and Çiğdem Seher Kasapkara EMAIL logo
Published/Copyright: June 23, 2021

Abstract

Objectives

Hereditary fructose intolerance (HFI) is an autosomal recessive disorder caused by a deficiency in aldolase B that can result in hypoglycemia, nausea, vomiting, abdominal pain, liver and kidney dysfunction, coma, and even death. This study aims to represent the clinical features and molecular genetic analysis data of the patients diagnosed with HFI in our study population.

Methods

The medical records of the 26 patients with HFI were evaluated retrospectively. Age, gender, clinical findings, metabolic crises, and the results of molecular analyses were recorded.

Results

The patients with HFI had a good prognosis and the aversion to sugar-containing foods was the main complaint. Seven different variants were identified in the Aldolase B (ALDOB) gene in HFI patients. The most frequent mutations were p.Ala150Pro, p.Ala175Asp had a prevalence of 61 and 30%, respectively, in agreement with the literature and other known variants were found with minor frequencies c.360-363del4(3.8%), p.Asn335Lys(3.8%), and three novel mutations c.113-1_15del4 (3.8%), p.Ala338Val(7.6%), and p.Asp156His(3.8%) were identified at a heterozygous, homozygous, or compound heterozygous level.

Conclusions

This study results revealed three novel mutations in patients with HFI. On the basis of age of presentation, clinical symptoms, and metabolic crisis, there was no clear-cut genotype-phenotype correlation. This article also demonstrates the importance of screening suspected infants in cases of acute liver failure for prompt diagnosis and treatment of HFI.


Corresponding author: Çiğdem Seher Kasapkara, Ankara Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkey, E-mail:

  1. Research funding: None.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Steinman, B, Santer, R. Disorders of fructose metabolism. In: Saudubray, JM, van den Berghe, G, Walter, JH, editors Inborn metabolic diseases, 5th ed. Heidelberg: Springer-Verlag Berlin; 2011.Search in Google Scholar

2. Rake, JP, Visser, G, Smit, GPA. Disorders of carbohydrate and glycogen metabolism. In: Blau, N, Hoffmann, GF, Leonard, J, Clarke, JTR, editors. Physician’s guide to the treatment and follow-up of metabolic diseases. Heidelberg: Springer; 2006.10.1007/3-540-28962-3_17Search in Google Scholar

3. Mayatepek, E, Hoffmann, B, Meissner, T. Inborn errors of carbohydrate metabolism. Best Pract Res Clin Gastroenterol 2010;24:607–18. https://doi.org/10.1016/j.bpg.2010.07.012.Search in Google Scholar

4. Steinmann, B, Gitzelmann, R, Van den Berghe, G. Disorders of fructose metabolism. In: Scriver, CR, Beaudet, AL, Sly, WS, Valle, D, editors. The metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill; 2001:1489–520 pp.Search in Google Scholar

5. Tolan, DR. Molecular basis of hereditary fructose intolerance:mutations and polymorphisms in the human aldolase B gene. Hum Mutat 1995;6:210–18. https://doi.org/10.1002/humu.1380060303.Search in Google Scholar

6. Buziau, AM, Schalkwijk, CG, Stehouwer, CDA, Tolan, DR, Brouwers, MCGJ. Recent advances in the pathogenesis of hereditary fructose intolerance: implications for its treatment and the understanding of fructose-induced non-alcoholic fatty liver disease. Cell Mol Life Sci 2020;77:1709–19. https://doi.org/10.1007/s00018-019-03348-2.Search in Google Scholar

7. Hegde, VS, Sharman, T. Hereditary fructose intolerance. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.Search in Google Scholar

8. el-Maghrabi, MR, Lange, AJ, Jiang, W, Yamagata, K, Stoffel, M, Takeda, J, et al.. Human fructose-1,6-bisphosphatase gene (FBP1): exon-intron organization, localization to chromosome bands 9q22.2-q22.3, and mutation screening in subjects with fructose-1,6-bisphosphatase deficiency. Genomics 1995;27:520–5. https://doi.org/10.1006/geno.1995.1085.Search in Google Scholar

9. McGrane, MM. Carbohydrate metabolism-synthesis and oxidation. In: Stipanuk, M, editor. Biochemical and physiological aspects of human nutrition. Philadelphia: W.B. Saunders Company; 2000.Search in Google Scholar

10. Coffee, EM, Tolan, DR. Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance. J Inherit Metab Dis 2010;33:715–25. https://doi.org/10.1007/s10545-010-9192-5.Search in Google Scholar

11. Coffee, EM, Yerkes, L, Ewen, EP, Zee, T, Tolan, DR. Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population. J Inherit Metab Dis 2010;33:33–42. https://doi.org/10.1007/s10545-009-9008-7.Search in Google Scholar

12. Cross, NCP, de Franchis, R, Sebastio, G, Dazzo, C, Tolan, DR, Gregori, C, et al.. Molecular analysis of aldolase B genes in hereditary fructose intolerance. Lancet 1990;335:306–9. https://doi.org/10.1016/0140-6736(90)90603-3.Search in Google Scholar

13. Davit-Spraul, A, Costa, C, Zater, M, Habes, D, Berthelot, J, Broué, P, et al.. Hereditary fructose intolerance: frequency and spectrum mutations of the aldolase B gene in a large patients cohort from France-Identification of eight new mutations. Mol Genet Metabol 2008;94:443–7. https://doi.org/10.1016/j.ymgme.2008.05.003.Search in Google Scholar PubMed

14. Dursun, A, Kalkanoğlu, HS, Coşkun, T, Tokatli, A, Bittner, R, Koçak, N, et al.. Mutation analysis in Turkish patients with hereditary fructose intolerance. J Inherit Metab Dis 2001;24:523–6. https://doi.org/10.1023/a:1012423624993.10.1023/A:1012423624993Search in Google Scholar

15. Yücel, D, Özgül, RK, Yılmaz, A, Tokatlı, A, Sivri, S, Coşkun, T, et al.. The spectrum and frequency of aldolase B gene mutations in Turkish patients with hereditary fructose intolerance. J Inherit Metab Dis 2010;33(1 Suppl):S67.Search in Google Scholar

16. Ferri, L, Caciotti, A, Cavicchi, C, Rigoldi, M, Parini, R, Caserta, M, et al.. Integration of PCR-sequencing analysis with multiplex ligation-dependent probe amplification for diagnosis of hereditary fructose intolerance. JIMD Rep 2012;6:31–7. https://doi.org/10.1007/8904_2012_125.Search in Google Scholar PubMed PubMed Central

17. Li, H, Byers, HM, Diaz-Kuan, A, Vos, MB, Hall, PL, Tortorelli, S, et al.. Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas. Mol Genet Metabol 2018;123:428–32. https://doi.org/10.1016/j.ymgme.2018.02.016.Search in Google Scholar PubMed

18. Esposito, G, Imperato, MR, Ieno, L, Sorvillo, R, Benigno, V, Parenti, G, et al.. Hereditary fructose intolerance: functional study of two novel ALDOB natural variants and characterization of a partial gene deletion. Hum Mutat 2010;31:1294–303. https://doi.org/10.1002/humu.21359.Search in Google Scholar PubMed

19. Bouteldja, N, Timson, DJ. The biochemical basis of hereditary fructose intolerance. J Inherit Metab Dis 2010;33:105–12. https://doi.org/10.1007/s10545-010-9053-2.Search in Google Scholar PubMed

Received: 2021-04-28
Accepted: 2021-05-25
Published Online: 2021-06-23
Published in Print: 2021-08-26

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Clinical characteristics and treatment patterns with histrelin acetate subcutaneous implants vs. leuprolide injections in children with precocious puberty: a real-world study using a US claims database
  4. High serum neurotensin level in obese adolescents is not associated with metabolic parameters, hyperphagia or food preference
  5. Increased lipocalin 2 levels in adolescents with type 2 diabetes mellitus
  6. Clinical, biochemical, and radiological follow-up results of children and adolescents with Hashimoto’s thyroiditis: a single-center experience
  7. Evaluation of children with type 1 diabetes mellitus in terms of overweight/obesity in tertiary care hospital
  8. Association between anthropometric measures and insulin resistance in Brazilian adolescents: data from the national study of cardiovascular risk factors in adolescents – ERICA
  9. Evaluation of metabolic parameters and aortic elasticity in normotensive children with premature adrenarche
  10. Molecular and clinical findings of Turkish patients with hereditary fructose intolerance
  11. Quantitation and evaluation of perinatal medium-chain and long-chain acylcarnitine blood concentrations in 12,000 full-term breastfed newborns
  12. Metabolic syndrome and cardiorespiratory fitness in children and adolescents: the role of obesity as a mediator
  13. Short Communication
  14. Transient neonatal hyperinsulinism: early predictors of duration
  15. Case Reports
  16. An extremely high blood glucose level in a child with hyperglycemic hyperosmolar state and type 1 diabetes
  17. Different clinical entities of the same mutation: a case report of three sisters with Wolfram syndrome and efficacy of dipeptidyl peptidase-4 inhibitor therapy
  18. Short report: craniosynostosis, a late complication of nutritional rickets
  19. Childhood obesity as a safeguarding issue: positive experiences with the “new home” environment as a treatment for weight management
Downloaded on 7.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0303/html
Scroll to top button